HISTORICAL ARTICLE
JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

Unique aspect of Tibetan medicine.

Tibetan medicine is known as the knowledge of healing in the Four Tantras, the main medical text studied by Tibetan doctors. In the 8th century, King Trisong Deutsen (718-785 CE) invited eminent physicians from India, China, Persia, East Turkestan, Mongolia, and Nepal for the First International Medical Symposium in Samye, Tibet and ordered his personal physician Elder Yuthog Yonten Gonpo (708-833 CE), who lived 125 years, and participated in this conference to summarize. By combining all the information available and presented during this symposium, he compiled the Four Tantras. He established the Tanadug medical school at Menlung in Kongpo, Southern Tibet in 763 CE, and worked for the propagation of Tibetan medicine. He is considered an emanation of Medicine Buddha, who is a symbol of mental and physical well being. In his left hand, the Medicine Buddha clasps a begging bowl with long-life nectar, signifying immortality, and in his right, the Chebulic myrobalan (Haritaki), a symbol of good health. Chebulic myrobalan, Belleric myrobalan, and Emblic myrobalan are together called the "3 Fruits" and are common ingredients in Tibetan medicines. Prof. Omura, Y of NY Medical College evaluated these "3 Fruits" and found that one of them available as a "Haritaki," had the highest normal cell telomere increasing effect by optimal dose, with improvement of circulation all over the body, which in turn inhibits cancer activity. He considered Tibetan medicine to be the most advanced medicine in the world before the 19th Century with its well-organized systematic method as described by colorful Tibetan medical paintings by Sangye Gyamtso (1653-1705 CE). During a typical diagnosis, the physician examines the patients' tongue, radial arteries for pulse beats by the index, middle, and ring fingers of both hands and the urine for features like color, vapor, and bubbles, etc.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app